GoodRx Holdings (GDRX) Gains from Investment Securities (2019 - 2025)
GoodRx Holdings' Gains from Investment Securities history spans 7 years, with the latest figure at $85000.0 for Q4 2025.
- On a quarterly basis, Gains from Investment Securities fell 45.16% to $85000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $240000.0, a 98.62% decrease, with the full-year FY2025 number at $9.2 million, up 348.17% from a year prior.
- Gains from Investment Securities hit $85000.0 in Q4 2025 for GoodRx Holdings, down from $155000.0 in the prior quarter.
- Over the last five years, Gains from Investment Securities for GDRX hit a ceiling of $18.7 million in Q1 2021 and a floor of -$523000.0 in Q4 2021.
- Historically, Gains from Investment Securities has averaged $3.8 million across 5 years, with a median of $444500.0 in 2021.
- The widest YoY moves for Gains from Investment Securities: up 1235.71% in 2021, down 100.6% in 2021.
- Tracing GDRX's Gains from Investment Securities over 5 years: stood at -$523000.0 in 2021, then skyrocketed by 1177.25% to $5.6 million in 2022, then soared by 206.05% to $17.2 million in 2023, then crashed by 99.1% to $155000.0 in 2024, then plummeted by 45.16% to $85000.0 in 2025.
- Business Quant data shows Gains from Investment Securities for GDRX at $85000.0 in Q4 2025, $155000.0 in Q4 2024, and $17.2 million in Q4 2023.